Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 524

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Micrometastases or Isolated Tumor Cells and the Outcome of Breast Cancer

Open access
de Boer, Maaike, van Deurzen, Carolien H.M., van Dijck, Jos A.A.M., Borm, George F., van Diest, Paul J., Adang, Eddy M.M., Nortier, Johan W.R., Rutgers, Emiel J.T., Seynaeve, Caroline, Menke-Pluymers, Marian B.E., Bult, Peter, Tjan-Heijnen, Vivianne C.G.·2009·New England Journal of Medicine

Abstract

BACKGROUND: The association of isolated tumor cells and micrometastases in regional lymph nodes with the clinical outcome of breast cancer is unclear. METHODS: We identified all patients in The Netherlands who underwent a sentinel-node biopsy for breast cancer before 2006 and had breast cancer with favorable primary-tumor characteristics and isolated tumor cells or micrometastases in the regional lymph nodes. Patients with node-negative disease were randomly selected from the years 2000 and 2001. The primary end point was disease-free survival. RESULTS: We identified 856 patients with node-negative disease who had not received systemic adjuvant therapy (the node-negative, no-adjuvant-therapy cohort), 856 patients with isolated tumor cells or micrometastases who had not received systemic adjuvant therapy (the node-positive, no-adjuvant-therapy cohort), and 995 patients with isolated tumor cells or micrometastases who had received such treatment (the node-positive, adjuvant-therapy cohort). The median follow-up was 5.1 years. The adjusted hazard ratio for disease events among patients with isolated tumor cells who did not receive systemic therapy, as compared with women with node-negative disease, was 1.50 (95% confidence interval [CI], 1.15 to 1.94); among patients with micrometastases, the adjusted hazard ratio was 1.56 (95% CI, 1.15 to 2.13). Among patients with isolated tumor cells or micrometastases, the adjusted hazard ratio was 0.57 (95% CI, 0.45 to 0.73) in the node-positive, adjuvant-therapy cohort, as compared with the node-positive, no-adjuvant-therapy cohort. CONCLUSIONS: Isolated tumor cells or micrometastases in regional lymph nodes were associated with a reduced 5-year rate of disease-free survival among women with favorable early-stage breast cancer who did not receive adjuvant therapy. In patients with isolated tumor cells or micrometastases who received adjuvant therapy, disease-free survival was improved.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa0904832

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 524

Metadata

Authors
de Boer, M., van Deurzen, C. H. M., van Dijck, J. A. A. M., Borm, G. F., van Diest, P. J., Adang, E. M. M., Nortier, J. W. R., Rutgers, E. J. T., Seynaeve, C., Menke-Pluymers, M. B. E., Bult, P., & Tjan-Heijnen, V. C. G.
Venue
New England Journal of Medicine
Published
2009-08-13
Volume
361
Issue
7
Pages
653-663
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2155090854
Cited by
524
References
12
FWCI
20.40
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Micrometastases or Isolated Tumor Cells and the Outcome of Breast Cancer. https://app.cochat.ai/papers/10.1056/nejmoa0904832
The paper
de Boer, M., van Deurzen, C. H. M., van Dijck, J. A. A. M., Borm, G. F., van Diest, P. J., Adang, E. M. M., Nortier, J. W. R., Rutgers, E. J. T., Seynaeve, C., Menke-Pluymers, M. B. E., Bult, P., & Tjan-Heijnen, V. C. G. (2009). Micrometastases or Isolated Tumor Cells and the Outcome of Breast Cancer. New England Journal of Medicine. https://doi.org/10.1056/nejmoa0904832

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.